Abstract:Background. Plasma S100A1 protein is a novel inflammatory biomarker associated with acute myocardial infarction and neurodegenerative disease's pathophysiological mechanisms. This study aimed to determine the levels of this protein in patients with acute ischemic stroke early in the disease progression and to investigate its role in the pathogenesis of acute ischemic stroke.Methods. A total of 192 participants from hospital stroke centers were collected for the study. Clinically pertinent data were recorded. The volume of the cerebral infarction was calculated according to the Pullicino formula. Multivariate logistic regression analysis was used to select independent influences. ROC curve was used to analyze the diagnostic value of AIS and TIA. The correlation between S100A1, NF -KB p65, and IL-6 levels and cerebral infarction volume was detected by Pearson correlation analysis.Results. There were statistically significant differences in S100A1, NF -KB p65, and IL-6 among the AIS,TIA, and PE groups (S100A1, [230.96 +/- 39.37] vs [185.85 +/- 43.24] vs [181.47 +/- 27.39], P < 0.001; NF -KB p65, [3.99 +/- 0.65] vs [3.58 +/- 0.74] vs [3.51 +/- 0.99], P = 0.001; IL-6, [13.32 +/- 1.57] vs [11.61 +/- 1.67] vs [11.42 +/- 2.34], P < 0.001). Multivariate logistic regression analysis showed that S100A1 might be an independent predictive factor for the diagnosis of disease (P < 0.001). The AUC of S100A1 for diagnosis of AIS was 0.818 (P < 0.001, 95% CI [0.749-0.887], cut off 181.03, J max 0.578, Se 95.0%, Sp 62.7%). The AUC of S100A1 for diagnosis of TIA was 0.720 (P = 0.001, 95% CI [0.592-0.848], cut off 150.14, J max 0.442, Se 50.0%, Sp 94.2%). There were statistically significant differences in S100A1, NF -KB p65, and IL-6 among the SCI,MCI, and LCI groups (S100A1, [223.98 +/- 40.21] vs [225.42 +/- 30.92] vs [254.25 +/- 37.07], P = 0.001; NF -KB p65, [3.88 +/- 0.66] vs [3.85 +/- 0.64] vs [4.41 +/- 0.45], P < 0.001; IL-6, [13.27 +/- 1.65] vs [12.77 +/- 1.31] vs [14.00 +/- 1.40], P = 0.007). Plasma S100A1, NF -KB p65, and IL-6 were significantly different from cerebral infarction volume (S100A1, r = 0.259, P = 0.002; NF -KB p65, r = 0.316, P < 0.001; IL-6, r = 0.177, P = 0.036). There was a positive correlation between plasma S100A1 and IL-6 with statistical significance (R = 0.353, P < 0.001). There was no significant positive correlation between plasma S100A1 and NF -KB p65 (R < 0.3), but there was statistical significance (R = 0.290, P < 0.001). There was a positive correlation between IL-6 and NF -KB p65 with statistical significance (R = 0.313, P < 0.001).Conclusion. S100A1 might have a better diagnostic efficacy for AIS and TIA. S100A1 was associated with infarct volume in AIS, and its level reflected the severity of acute cerebral infarction to a certain extent. There was a correlation between S100A1 and IL-6 and NF -KB p65, and it was reasonable to speculate that this protein might mediate the inflammatory response through the NF -KB pathway during the pathophysiology of AIS.

NERVE GROWTH FACTOR AND S100B IN BLOOD AND CEREBROSPINAL FLUID AS INDICATORS OF THE SEVERITY OF ISCHEMIC STROKE

High S100B Levels in Cerebrospinal Fluid and Peripheral Blood of Patients with Acute Basal Ganglial Hemorrhage Are Associated with Poor Outcome.

Diagnostic value and mechanism of plasma S100A1 protein in acute ischemic stroke: a prospective and observational study

Predicting Short- and Long-Term Functional Outcomes Based on Serum S100B Protein Levels in Patients with Ischemic Stroke

Elevated serum miR-142-5p correlates with ischemic lesions and both NSE and S100β in ischemic stroke patients

Acute Neurofilament Light Chain Plasma Levels Correlate With Stroke Severity and Clinical Outcome in Ischemic Stroke Patients

Inflammatory biomarkers in blood of patients with acute brain ischemia

Serum neurofilament light chain: a predictive marker for outcomes following mild-to-moderate ischemic stroke

Relationship between cerebrospinal fluidα-Synuclein and prognosis of patients with traumatic brain injury

Serum Neurofilament Light Predicts Severity and Prognosis in Patients with Ischemic Stroke

Levels of Phosphorylated Axonal Neurofilament Subunit H (pnfh) Are Increased in Acute Ischemic Stroke.

The Association of Serum Neurofilament Light Chain and Acute Ischaemic Stroke Is Influenced by Effective Revascularization

Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke

Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke

Neurofilament light chain and S100B serum levels are associated with disease severity and outcome in patients with aneurysmal subarachnoid hemorrhage

Systemic immune-inflammation index and serum glucose-potassium ratio predict poor prognosis in patients with spontaneous cerebral hemorrhage: An observational study

To study the correlation of serum S-100 protein level with the severity of stroke and its prognostic implication

Circulating levels of neurofilament light chain as a biomarker of infarct and white matter hyperintensity volumes after ischemic stroke

Predictive role of neuron-specific enolase and S100-β in early neurological deterioration and unfavorable prognosis in patients with ischemic stroke

Change of serum soluble intercellular adhesion molecule and basic fibroblast growth factor in patients with acute cerebral infarction and its clinical significance]

Changes and Clinical Significance of Serum IL-6,sICAM-1 in Patients with Cerebral Infarcts